liver cancer
Helio Genomics Sister Firm LAMH Receives NMPA Approval in China for Blood-Based Liver Cancer Test
The liquid biopsy assay is a modified version of Helio's HelioLiver test that is tailored to the unique genetic makeup of the Asia-Pacific population.
Culmination Bio, Cofactor Genomics Team up on Study to Advance Immunotherapy Response Test
Culmination will give Cofactor access to over 4.5 million biological samples to advance the firm's assay to predict immunotherapy response in 11 cancer types.
Liver Cancers Detected With Parallel Mutation, Methylation Liquid Biopsy Approach
Using a strategy they developed, researchers profiled liver cancer-related mutations and methylation changes in cell-free DNA, finding predictive markers.
Liver Cancer Detection Score Developed With Machine Learning Analysis of Blood Plasma DNA Fragments
Researchers used machine learning to come up with a cell-free DNA 'fragmentome'-based score for finding hepatocellular carcinoma cases from blood plasma samples.
Liver Disease Multiomic Analysis Reveals Detection Clues, Points to Treatment Strategies
Researchers found nonalcoholic fatty liver disease markers with a combination of genome-wide association analyses, blood gene expression profiling, and blood plasma proteomics.